000 03271cam a2200349 a 4500
003 EG-GiCUC
005 20250223031933.0
008 180222s2016 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aM.Sc
099 _aCai01.11.06.M.Sc.2016.Na.L
100 0 _aNaef Gumaan Salem Ba haretha
245 1 0 _aLeptin as local inflammatory marker in COPD exacerbation /
_cNaef Gumaan Salem Ba haretha ; Supervised Hossam Hosny Masoud , Ahmed Mahmoud Abdelhafeez , Mohamed Said Ismail
246 1 5 _aاللبيتن كدليل إلتهاب موضعي لمرض السدة الرئوية المستثار
260 _aCairo :
_bNaef Gumaan Salem Ba haretha ,
_c2016
300 _a194 P. :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Chest Diseases and Tuberculosis
520 _aBackground : Chronic inflammation of the lung is a characteristic finding in chronic obstructive pulmonary disease (COPD). Leptin is a pleiotropic cytokine thought to play a role in host response to inflammation. As recent studies have shown that leptin receptors are present in the lung, this study aimed to determine if leptin is detectable in induced sputum of COPD stable and exacerbation patients if there is a relationship between sputum leptin and other inflammatory markers in serum Aim of the work: This study aimed to detect sputum leptin and serum TNF-alpha and CRP levels in COPD patients without weight loss during stable disease and acute exacerbation, and to investigate relationships between sputum leptin, serum TNF-alpha and serum CRP in COPD exacerbation.Subjects and methods: 20 stable COPD patients, 20 COPD patients with acute exacerbation and 12 control subjects participated in this study. To eliminate the effects of sex differences, all patients and controls were male. BMI, percent ideal body weight (19-29), percent , TLC, ESR and sputum leptin, serum TNF-alpha and serum CRP levels in day 0 and day 7 were measured in exacerbation and only one in stable patients and healthy individuals (control). Sputum and serum Leptin, TNF-alpha and CRP levels were measured by ELISA.Results: In chronic obstructive disease exacerbation was statistically significant difference between sputum, serum leptin TNF-Ü and CRP levels, before and after treatment. Sputum leptin and serum CRP levels were significantly higher in the patients exacerbation than in the stable patients and healthy individuals (controls). Additionally, Sputum leptin, TNF serum and CRP levels were significantly higher in the patients exacerbation than in the healthy individuals (controls). As regards the correlation between sputum, serum leptin, TNF-Ü and CRP levels with COPD stable patients and healthy individuals (control), it was found insignificant
530 _aIssued also as CD
653 4 _aCOPD
653 4 _aExacerbation
653 4 _aLeptin hormone
700 0 _aAhmed Mahmoud Abdelhafeez ,
_eSupervisor
700 0 _aHossam Hosny Masoud ,
_eSupervisor
700 0 _aMohamed Said Ismail ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aEnas
_eCataloger
905 _aNazla
_eRevisor
942 _2ddc
_cTH
999 _c65125
_d65125